Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritis

Rheumatoid Arthritis

Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial

Ann Rheum Dis

Lend K, Lampa J, Padyukov L, Hetland ML, Heiberg MS, Nordström DC, Nurmohamed MT, Rudin A, Østergaard M, Haavardsholm EA, Hørslev-Petersen K, Uhlig T, Sokka-Isler T, Gudbjornsson B, Grondal G, Frazzei G, Christiaans J, Wolbink G, Rispens T, Twisk JWR, van Vollenhoven RF

doi: 10.1136/ard-2024-226024

Rheumatoid Arthritis

Predictors of arthritis development in individuals at risk of rheumatoid arthritis: a 5-year follow-up study from a large cohort

Ann Rheum Dis

Frazzei G, Landewé RBM, Wagenaar C, van de Stadt LA, van Schaardenburg D, Tas SW, van Vollenhoven RF

doi: 10.1016/j.ard.2025.01.042

Rheumatoid Arthritis

The Veterans Affairs Rheumatoid Arthritis Registry: A unique population in rheumatoid arthritis research

Semin Arthritis Rheum

Mikuls TR, Baker JF, Cannon GW, England BR, Kerr G, Reimold A

doi: 10.1016/j.semarthrit.2024.152580

Rheumatoid Arthritis

Association between sleep disturbance and subsequent pain interference in patients with early rheumatoid arthritis

Arthritis Care Res (Hoboken)

Aydemir B, Schieir O, Valois MF, Muhammad LN, Song J, Dunlop D, Chang RW, Bartlett SJ, Bessette L, Boire G, Hazlewood G, Hitchon C, Pope J, Thorne C, Tin D, Bykerk VP, Lee YC

doi: 10.1002/acr.25568

Rheumatoid Arthritis

Machine learning in the prediction of treatment response in rheumatoid arthritis: A systematic review

Semin Arthritis Rheum

Mendoza-Pinto C, Sánchez-Tecuatl M, Berra-Romani R, Maya-Castro ID, Etchegaray-Morales I, Munguía-Realpozo P, Cárdenas-García M, Arellano-Avendaño FJ, García-Carrasco M

doi: 10.1016/j.semarthrit.2024.152501

Rheumatoid Arthritis

Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study

Lancet Rheumatol

Russell MD, Gibson M, Zuckerman B, Kumar K, Dubey S, Adas MA, Alveyn E, Patel S, Yang Z, Bechman K, Price E, Gallagher S, Cope AP, Norton S, Galloway JB

doi: 10.1016/S2665-9913(24)00221-2

Rheumatoid Arthritis

Barriers to, Facilitators of, and Interventions to Support Treat-to-Target Implementation in Rheumatoid Arthritis: A Systematic Review

Arthritis Care Res (Hoboken)

Gossec L, Bessette L, Xavier RM, Favalli EG, Östör A, Buch MH

doi: 10.1002/acr.25408

Rheumatoid Arthritis

Machine Learning Analysis of Whole-Blood Transcriptomics Data in Rheumatoid Arthritis Patients Treated with Adalimumab Identifies Predictive Biomarkers of Response

Arthritis Rheumatol

Yap CF, Nair N, Morgan AW, Isaacs JD, Wilson AG, Hyrich K, Barturen G, Riva-Torrubia M, Gut M, Gut I, Alarcón Riquelme ME, Barton A, Plant D

doi: 10.1002/art.43255

Rheumatoid Arthritis

Time-independent disease state identification defines distinct trajectories determined by localised vs systemic inflammation in patients with early rheumatoid arthritis

Ann Rheum Dis

Steinz N, Maarseveen TD, van den Akker EB, Cope AP, Isaacs JD, Winkler AR, Huizinga TWJ, Abraham Y, Knevel R

doi: 10.1016/j.ard.2025.04.011

Related content

Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial

Predictors of arthritis development in individuals at risk of rheumatoid arthritis: a 5-year follow-up study from a large cohort

The Veterans Affairs Rheumatoid Arthritis Registry: A unique population in rheumatoid arthritis research

Association between sleep disturbance and subsequent pain interference in patients with early rheumatoid arthritis

Machine learning in the prediction of treatment response in rheumatoid arthritis: A systematic review

Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study

Barriers to, Facilitators of, and Interventions to Support Treat-to-Target Implementation in Rheumatoid Arthritis: A Systematic Review

Machine Learning Analysis of Whole-Blood Transcriptomics Data in Rheumatoid Arthritis Patients Treated with Adalimumab Identifies Predictive Biomarkers of Response

Time-independent disease state identification defines distinct trajectories determined by localised vs systemic inflammation in patients with early rheumatoid arthritis